We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
-17.92%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$869M
AUM Growth
-$96.9M
(-10%)
Cap. Flow
+$145M
Cap. Flow
% of AUM
16.68%
Top 10 Holdings %
Top 10 Hldgs %
61.15%
Holding
62
New
17
Increased
11
Reduced
13
Closed
12
Top Buys
| 1 |
argenx
ARGX
|
+$73.3M |
| 2 |
Xencor
XNCR
|
+$36.3M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$33.3M |
| 4 |
Solid Biosciences
SLDB
|
+$27.2M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$25.8M |
Top Sells
| 1 |
MacroGenics
MGNX
|
+$31.8M |
| 2 |
Ascendis Pharma A/S
ASND
|
+$25.6M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$22.2M |
| 4 |
Scholar Rock
SRRK
|
+$20.2M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
+$19.4M |
Sector Composition
| 1 | Healthcare | 89.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
argenx
ARGX
$54.1B
| $79.3M | 9.12% |
+825,087
| New | +$73.3M |
|
2
Kura Oncology
KURA
$1B
| $74.1M | 8.52% |
5,276,753
+1,373,778
| +35% | +$18.2M |
|
|
KYNB
3
Kyntra Bio
KYNB
$29.8M
| $70.6M | 8.12% |
60,982
-19,708
| -24% | -$22.2M |
|
4
Ironwood Pharmaceuticals
IRWD
$665M
| $55.8M | 6.41% |
6,425,251
+286,152
| +5% | +$3.28M |
|
5
Assembly Biosciences
ASMB
$531M
| $54.4M | 6.26% |
200,404
-44,860
| -18% | -$13M |
|
|
ONCE
6
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $44.5M | 5.12% |
1,136,851
+299,803
| +36% | +$13M |
|
|
7
Ascendis Pharma A/S
ASND
$17.6B
| $42.6M | 4.9% |
679,746
-407,511
| -37% | -$25.6M |
|
|
8
Ionis Pharmaceuticals
IONS
$8.96B
| $39.2M | 4.51% |
725,326
+653,000
| +903% | +$33.3M |
|
|
9
Xencor
XNCR
$1.11B
| $35.8M | 4.11% |
+989,018
| New | +$36.3M |
|
|
DRNA
10
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $35.5M | 4.08% |
3,316,407
-485,920
| -13% | -$6.39M |
|
|
11
Scholar Rock
SRRK
$6.46B
| $33.9M | 3.9% |
1,474,228
-893,150
| -38% | -$20.2M |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $27.5M | 3.16% |
+647,169
| New | +$25.8M |
|
|
KZR
13
DELISTED
Kezar Life Sciences
KZR
| $25M | 2.88% |
106,002
-22,818
| -18% | -$5.58M |
|
|
14
Solid Biosciences
SLDB
$947M
| $23.2M | 2.67% |
+57,816
| New | +$27.2M |
|
|
AKCA
15
DELISTED
Akcea Therapeutics Inc
AKCA
| $19.3M | 2.22% |
639,743
-115,377
| -15% | -$3.23M |
|
|
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $16.2M | 1.86% |
53,188
+18,538
| +54% | +$5.99M |
|
|
UBX
17
DELISTED
Unity Biotechnology
UBX
| $15.7M | 1.81% |
96,711
| – | – |
|
|
SGMO
18
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $13.6M | 1.57% |
1,185,831
+842,600
| +245% | +$10.5M |
|
19
Zai Lab
ZLAB
$2.3B
| $13.2M | 1.52% |
569,377
+219,377
| +63% | +$4.07M |
|
20
Arcus Biosciences
RCUS
$3.53B
| $13.2M | 1.52% |
1,223,495
-1,012,892
| -45% | -$11.8M |
|
21
Arbutus Biopharma
ABUS
$889M
| $12.6M | 1.45% |
3,281,502
+2,049,702
| +166% | +$10.1M |
|
|
MYOK
22
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $11.5M | 1.32% |
+234,381
| New | +$12.9M |
|
23
Rhythm Pharmaceuticals
RYTM
$7.52B
| $10.8M | 1.24% |
+400,838
| New | +$11.1M |
|
24
Wave Life Sciences
WVE
$1.14B
| $9.84M | 1.13% |
233,933
+189,092
| +422% | +$8.41M |
|
|
SURF
25
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $9.59M | 1.1% |
2,261,328
+897,849
| +66% | +$6.93M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM